PF
Profarma Distribuidora de Produtos Farmacêuticos S.A.
PFRM3.SA · SAO
R$ 8.58 +11.43% (+R$ 0.88)
1M -0.39%
Market Cap R$ 1.05B
P/E Ratio 6.81x
Div. Yield 7.51%
ROE 11.21%
Bulios Fair Price
R$ 10.2
18.9% upside
Current Price
R$ 8.58
Undervalued Fair Value Overvalued
According to Bulios Fair Price, PFRM3.SA is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
5/9Valuation
94 /100
Cheap P/FCF 3.54x
P/S 0.08x
P/B 0.73x
Growth
77 /100
Growing Rev. growth 13.57%
FCF growth 17.97%
Book val. growth 4.16%
Profitability
17 /100
Weak Net margin 1.24%
Op. margin 3.34%
FCF margin 2.38%
Quality
51 /100
Average ROE 11.21%
ROA 1.94%
Asset turnover 1.56x
Debt
44 /100
Moderate Current ratio 1.37x
Int. coverage 1.41x
Net debt/EBITDA 2.30x
Stability
69 /100
Stable Rev. volatility 3.28%
EPS volatility 40.17%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PFRM3.SA
Online
Sector
Healthcare
Industry
Medical - Distribution
CEO
Sammy Birmarcker
Employees
7,077
Headquarters
Rio De Janeiro